Rural Health
Resources by Topic: Opioids
COVID-19 During the Opioid Epidemic – Exacerbation of Stigma and Vulnerabilities
Explores how the lack of healthcare infrastructure in rural areas and the COVID-19 pandemic create particular challenges for people who use drugs (PWUDs). Discusses the stigma of seeking care during a pandemic and the difficulty of accessing living resources, among other issues affecting PWUDs in rural areas.
Author(s): Wiley D. Jenkins, Rebecca Bolinski, John Bresett, et al.
Citation: Journal of Rural Health, 37(1), 172-174
Date: 01/2021
view details
Explores how the lack of healthcare infrastructure in rural areas and the COVID-19 pandemic create particular challenges for people who use drugs (PWUDs). Discusses the stigma of seeking care during a pandemic and the difficulty of accessing living resources, among other issues affecting PWUDs in rural areas.
Author(s): Wiley D. Jenkins, Rebecca Bolinski, John Bresett, et al.
Citation: Journal of Rural Health, 37(1), 172-174
Date: 01/2021
view details
A Primary Care Response to COVID‐19 for Patients with an Opioid Use Disorder
Discusses the challenges of treating patients with opioid use disorder (OUD) during the COVID-19 pandemic. Highlights decisions made by primary care physicians regarding harm reduction related to COVID-19 that may have detrimental effects for OUD patient.
Author(s): Courtenay Gilmore Wilson, Melinda Ramage, E. Blake Fagan
Citation: Journal of Rural Health, 37(1), 169-171
Date: 01/2021
view details
Discusses the challenges of treating patients with opioid use disorder (OUD) during the COVID-19 pandemic. Highlights decisions made by primary care physicians regarding harm reduction related to COVID-19 that may have detrimental effects for OUD patient.
Author(s): Courtenay Gilmore Wilson, Melinda Ramage, E. Blake Fagan
Citation: Journal of Rural Health, 37(1), 169-171
Date: 01/2021
view details
Using Technology-Based Therapeutic Tools in Behavioral Health Services
Report discusses the use of telehealth to provide behavioral health services. Explores the benefits of telehealth as a bridge to accessing behavioral healthcare and presents implementation guidance, such as state and licensing regulations and reimbursement considerations.
Date: 2021
Sponsoring organization: Substance Abuse and Mental Health Services Administration
view details
Report discusses the use of telehealth to provide behavioral health services. Explores the benefits of telehealth as a bridge to accessing behavioral healthcare and presents implementation guidance, such as state and licensing regulations and reimbursement considerations.
Date: 2021
Sponsoring organization: Substance Abuse and Mental Health Services Administration
view details
Treating a Public Health Crisis for Rural Moms – A Comparative Analysis of Four Rural States Addressing Maternal Opioid Misuse with Medicaid Innovation Models
Discusses how 4 states - Colorado, Indiana, Maine, and Missouri - have used the Maternal Opioid Misuse (MOM) model to address maternal opioid use disorders among rural Medicaid beneficiaries. Compares different approaches taken by each state, including benefit eligibility, health insurance payers and health systems partnerships, and telehealth utilization.
Author(s): Jason Semprini
Citation: Online Journal of Rural Research & Policy, 16(2)
Date: 2021
view details
Discusses how 4 states - Colorado, Indiana, Maine, and Missouri - have used the Maternal Opioid Misuse (MOM) model to address maternal opioid use disorders among rural Medicaid beneficiaries. Compares different approaches taken by each state, including benefit eligibility, health insurance payers and health systems partnerships, and telehealth utilization.
Author(s): Jason Semprini
Citation: Online Journal of Rural Research & Policy, 16(2)
Date: 2021
view details
Community of Practice: Preventing and Reducing the Stigma of Substance Use Disorders in Rural Communities - Implementation and Lessons Learned
Report discusses strategies for reducing stigma around substance use disorders (SUDs) and SUD treatment in rural communities. Details the implementation of Communities of Practice sessions with participants and breaks down participant data and session timeline.
Date: 2021
Sponsoring organizations: Great Lakes PTTC, Prevention Technology Transfer Center Network
view details
Report discusses strategies for reducing stigma around substance use disorders (SUDs) and SUD treatment in rural communities. Details the implementation of Communities of Practice sessions with participants and breaks down participant data and session timeline.
Date: 2021
Sponsoring organizations: Great Lakes PTTC, Prevention Technology Transfer Center Network
view details
Opioid Initiation and Injection Transition in Rural Northern New England: A Mixed-methods Approach
Highlights a study on opioid initiation and transition to opioid injection in rural New England. Bases findings on interviews with opioid users in 11 rural counties in Massachusetts, Vermont, and New Hampshire. Tracks the time and circumstances of first opioid use to first opioid injection.
Author(s): Kerry Nolte, Aurora L. Drew, Peter D. Friedmann, et al.
Citation: Drug and Alcohol Dependence, 217(1), 108256
Date: 12/2020
view details
Highlights a study on opioid initiation and transition to opioid injection in rural New England. Bases findings on interviews with opioid users in 11 rural counties in Massachusetts, Vermont, and New Hampshire. Tracks the time and circumstances of first opioid use to first opioid injection.
Author(s): Kerry Nolte, Aurora L. Drew, Peter D. Friedmann, et al.
Citation: Drug and Alcohol Dependence, 217(1), 108256
Date: 12/2020
view details
Prevalence and Geographic Distribution of Obstetrician-Gynecologists Who Treat Medicaid Enrollees and Are Trained to Prescribe Buprenorphine
Highlights a study on the geographic distribution of Medicaid-claimant obstetrician-gynecologists trained to prescribe buprenorphine for opioid use disorder. Compares provider prevalence in rural versus urban counties.
Author(s): Max Jordan Nguemeni Tiako, Jennifer Culhane, Eugenia South, et al.
Citation: JAMA Network Open, 3(12), e2029043
Date: 12/2020
view details
Highlights a study on the geographic distribution of Medicaid-claimant obstetrician-gynecologists trained to prescribe buprenorphine for opioid use disorder. Compares provider prevalence in rural versus urban counties.
Author(s): Max Jordan Nguemeni Tiako, Jennifer Culhane, Eugenia South, et al.
Citation: JAMA Network Open, 3(12), e2029043
Date: 12/2020
view details
How Does DATA-Waiver Provider Patient Capacity Relate to Opioid and Buprenorphine Prescribing?
Explores if regulatory changes to increase the patient capacity among buprenorphine waivered providers effects buprenorphine and opioids prescription rates at the county-level. Compares prescription rates by metropolitan and nonmetropolitan counties.
Author(s): Robin Ghertner, Mir M. Ali
Date: 12/2020
Sponsoring organization: HHS Office of the Assistant Secretary for Planning and Evaluation
view details
Explores if regulatory changes to increase the patient capacity among buprenorphine waivered providers effects buprenorphine and opioids prescription rates at the county-level. Compares prescription rates by metropolitan and nonmetropolitan counties.
Author(s): Robin Ghertner, Mir M. Ali
Date: 12/2020
Sponsoring organization: HHS Office of the Assistant Secretary for Planning and Evaluation
view details
Medicare Fee-For-Service Beneficiaries with Opioid Use Disorder in 2018: Disparities in Prevalence by Beneficiary Characteristics
Examines the sociodemographic, Medicare eligibility, clinical, and geographic characteristics of Medicare beneficiaries with opioid use disorder (OUD). Identifies disparities in OUD prevalence among Medicare beneficiaries. Discusses opportunities to tailor policies and interventions to beneficiary groups with high OUD prevalence to ensure access to treatment.
Date: 12/2020
Sponsoring organization: Centers for Medicare & Medicaid Services
view details
Examines the sociodemographic, Medicare eligibility, clinical, and geographic characteristics of Medicare beneficiaries with opioid use disorder (OUD). Identifies disparities in OUD prevalence among Medicare beneficiaries. Discusses opportunities to tailor policies and interventions to beneficiary groups with high OUD prevalence to ensure access to treatment.
Date: 12/2020
Sponsoring organization: Centers for Medicare & Medicaid Services
view details
Opioids in Medicaid: Concerns About Opioid Use Among Beneficiaries in Six Appalachian States in 2018
Examines the rates of opioid use of Medicaid beneficiaries in 6 Appalachian states in 2018. Discusses the amount of the prescriptions issued, the amounts of opioids received, and the amount of providers with questionable prescribing practices, among other opioid-related measures.
Date: 12/2020
Sponsoring organization: Office of Inspector General (HHS)
view details
Examines the rates of opioid use of Medicaid beneficiaries in 6 Appalachian states in 2018. Discusses the amount of the prescriptions issued, the amounts of opioids received, and the amount of providers with questionable prescribing practices, among other opioid-related measures.
Date: 12/2020
Sponsoring organization: Office of Inspector General (HHS)
view details